NASDAQ:KALV - Kalvista Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$22.83 -0.97 (-4.08 %)
(As of 05/20/2019 01:07 PM ET)
Previous Close$23.80
Today's Range$22.77 - $23.74
52-Week Range$7.73 - $34.92
Volume2,890 shs
Average Volume118,635 shs
Market Capitalization$393.82 million
P/E RatioN/A
Dividend YieldN/A
Beta2.32

Analyst Ratings

Kalvista Pharmaceuticals (NASDAQ:KALV) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Kalvista Pharmaceuticals in the last 12 months. Their average twelve-month price target is $31.75, suggesting that the stock has a possible upside of 39.07%. The high price target for KALV is $35.00 and the low price target for KALV is $30.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $31.75$29.25$27.3333$27.3333
Price Target Upside: 39.07% upside3.65% upside21.16% upside41.62% upside

Kalvista Pharmaceuticals (NASDAQ:KALV) Consensus Price Target History

Price Target History for Kalvista Pharmaceuticals (NASDAQ:KALV)

Kalvista Pharmaceuticals (NASDAQ:KALV) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/15/2019Roth CapitalBoost Price TargetBuy$25.00 ➝ $30.00HighView Rating Details
3/20/2019Needham & Company LLCInitiated CoverageBuy$35.00LowView Rating Details
12/14/2018Cantor FitzgeraldReiterated RatingBuy$32.00LowView Rating Details
10/30/2018Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$30.00MediumView Rating Details
10/15/2018Stifel NicolausInitiated CoverageBuyHighView Rating Details
4/29/2018BTIG ResearchReiterated RatingBuyMediumView Rating Details
(Data available from 5/20/2017 forward)
This page was last updated on 5/20/2019 by MarketBeat.com Staff

Featured Article: What is systematic risk?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel